You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diroximel Fumarate

Showing 1 - 25 of 568
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial (Diroximel Fumarate, Avonex, Tysabri)

Not yet recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +3 more
  • (no location specified)
Dec 12, 2022

Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate

Recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +8 more
  • Eden Prairie, Minnesota
    OptumInsight
Jan 9, 2023

Diroximel Fumarate Real-world Experience in Canada and Israel

Recruiting
  • Relapsing Forms of MS
  • Diroximel Fumarate
  • Haifa, Israel
  • +5 more
Jan 31, 2023

Healthy Volunteers Trial in Sha Tin, Christchurch (Diroximel fumarate)

Completed
  • Healthy Volunteers
  • Diroximel fumarate
  • Sha Tin, New Territories, Hong Kong
  • +1 more
Jul 1, 2022

Study of Diroximel Fumarate in the Real-World Setting

Recruiting
  • Relapsing Forms of MS
  • Diroximel Fumarate
  • Washington, District of Columbia
  • +11 more
May 9, 2022

Relationship Between Oral DMT Burden and Adherence in MS

Enrolling by invitation
  • Multiple Sclerosis
  • Adherence, Medication
  • Melbourne, Victoria, Australia
    Monash University
Aug 28, 2022

Long-Term Safety of Vumerity and Tecfidera in Multiple Sclerosis

Not yet recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +2 more
  • (no location specified)
Mar 2, 2023

Relapsing Forms of Multiple Sclerosis Trial (BIIB091, DRF, Placebo)

Not yet recruiting
  • Relapsing Forms of Multiple Sclerosis
  • (no location specified)
Mar 23, 2023

Relapsing Forms of Multiple Sclerosis Trial in China, Japan (Diroximel fumarate)

Recruiting
  • Relapsing Forms of Multiple Sclerosis
  • Diroximel fumarate
  • Tianjin, China
  • +23 more
Jul 22, 2022

Relapsing Remitting Multiple Sclerosis Trial in Saint Louis (Monomethyl Fumarate 190 Mg, Diroximel Fumarate 462 mg)

Completed
  • Relapsing Remitting Multiple Sclerosis
  • Monomethyl Fumarate 190 Mg
  • Diroximel Fumarate 462 mg
  • Saint Louis, Missouri
    BioPharma Services, Inc.
Dec 20, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in United Kingdom, United States (Early Highly Effective Therapies Group,

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Highly Effective Therapies Group
  • Escalation Therapies Group
  • Aurora, Colorado
  • +30 more
Jul 22, 2022

Antibody Response to COVID19 Vaccination in Multiple Sclerosis

Completed
  • Multiple Sclerosis
  • Covid19
    • Livingston, New Jersey
      Saint Barnabas Medical Center
    Aug 16, 2022

    COVID-19 Vaccination in Multiple Sclerosis Treated With Immune

    Active, not recruiting
    • Multiple Sclerosis
    • Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus
    • Portland, Oregon
      Providence Neurological Specialties West
    Sep 1, 2022

    Relapsing Multiple Sclerosis Trial in Worldwide (Ofatumumab)

    Recruiting
    • Relapsing Multiple Sclerosis
    • Ofatumumab
    • Cullman, Alabama
    • +165 more
    Jan 13, 2023

    Relapsing Remitting Multiple Sclerosis Trial in Portland (3 mg Melatonin, 5 mg Melatonin)

    Active, not recruiting
    • Relapsing Remitting Multiple Sclerosis
    • 3 mg Melatonin
    • 5 mg Melatonin
    • Portland, Oregon
      Providence MS Center
    May 5, 2022

    Multiple Sclerosis Trial in Boston (Electronic Pill Bottle)

    Completed
    • Multiple Sclerosis
    • Electronic Pill Bottle
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 26, 2021

    Multiple Sclerosis, Relapsing-Remitting Trial in United States (Early Aggressive Therapy or Traditional Therapy)

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Early Aggressive Therapy or Traditional Therapy
    • Birmingham, Alabama
    • +51 more
    Jan 23, 2023

    COPD Trial in Worldwide (Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate, Treatment B: Budesonide and

    Not yet recruiting
    • Chronic Obstructive Pulmonary Disease
    • Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate
    • +2 more
    • Torrance, California
    • +25 more
    Sep 28, 2023

    Relapsing Remitting Multiple Sclerosis Trial (monomethyl fumarate 190 mg, dimethyl fumarate 240 mg)

    Completed
    Has Results
    • Relapsing Remitting Multiple Sclerosis
    • monomethyl fumarate 190 mg
    • dimethyl fumarate 240 mg
    • (no location specified)
    Dec 5, 2022

    Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Dimethyl Fumarate, Peginterferon Beta-1a, Placebo)

    Terminated
    • Multiple Sclerosis, Relapsing-Remitting
    • Dimethyl Fumarate
    • +2 more
    • Raleigh, North Carolina
    • +22 more
    Nov 30, 2022

    Intracranial Aneurysm, Aneurysm, Brain, Inflammation Vascular Trial in Beijing (Dimethyl fumarate, Placebo)

    Not yet recruiting
    • Intracranial Aneurysm
    • +2 more
    • Dimethyl fumarate
    • Placebo
    • Beijing, Beijing, China
      Beijing Neurosurgical Institute & Beijing Tiantan Hospital
    Jul 16, 2023

    Bafiertam Treatment In Routine Clinical Practice

    Enrolling by invitation
    • Relapsing Remitting Multiple Sclerosis
    • Monomethyl Fumarate
    • West Hollywood, California
    • +1 more
    Aug 3, 2023

    Chronic Hepatitis B Trial in Monterey Park (NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg)

    Completed
    • Chronic Hepatitis B
    • NCO-48 Fumarate 4 mg
    • +2 more
    • Monterey Park, California
      National Institute of Clinical Research, Inc
    Jan 3, 2023

    Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%

    Not yet recruiting
    • Allergic Conjunctivitis
    • rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
    • Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
    • (no location specified)
    Apr 4, 2023

    Efficacy, Safety, Pharmacokinetics Trial in Jilin (Hepenofovir Fumarate Tablets)

    Recruiting
    • Efficacy
    • +2 more
    • Hepenofovir Fumarate Tablets
    • Jilin, Changchun, China
      The First Hospital of Jilin University
    Nov 2, 2023